137 related articles for article (PubMed ID: 38590052)
1. Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush.
Clarke-Deelder E; Suharlim C; Chatterjee S; Portnoy A; Brenzel L; Ray A; Cohen JL; Menzies NA; Resch SC
Health Policy Plan; 2024 Jun; 39(6):583-592. PubMed ID: 38590052
[TBL] [Abstract][Full Text] [Related]
2. Impact of campaign-style delivery of routine vaccines: a quasi-experimental evaluation using routine health services data in India.
Clarke-Deelder E; Suharlim C; Chatterjee S; Brenzel L; Ray A; Cohen JL; McConnell M; Resch SC; Menzies NA
Health Policy Plan; 2021 May; 36(4):454-463. PubMed ID: 33734362
[TBL] [Abstract][Full Text] [Related]
3. The incremental cost of improving immunization coverage in India through the Intensified Mission Indradhanush programme.
Chatterjee S; Das P; Pinheiro A; Haldar P; Ray A; Brenzel L; Resch S
Health Policy Plan; 2021 Sep; 36(8):1316-1324. PubMed ID: 33950262
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
Gupta M; Prinja S; Kumar R; Kaur M
Health Policy Plan; 2013 Jan; 28(1):51-61. PubMed ID: 22407018
[TBL] [Abstract][Full Text] [Related]
5. Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush.
Summan A; Nandi A; Deo S; Laxminarayan R
Ann N Y Acad Sci; 2021 Oct; 1502(1):110-120. PubMed ID: 34263929
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.
Russell LB; Kim SY; Cosgriff B; Pentakota SR; Schrag SJ; Sobanjo-Ter Meulen A; Verani JR; Sinha A
Vaccine; 2017 Dec; 35(49 Pt B):6905-6914. PubMed ID: 29129451
[TBL] [Abstract][Full Text] [Related]
8. Impact and cost effectiveness of pneumococcal conjugate vaccine in India.
Krishnamoorthy Y; Eliyas SK; Nair NP; Sakthivel M; Sarveswaran G; Chinnakali P
Vaccine; 2019 Jan; 37(4):623-630. PubMed ID: 30587430
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
11. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
[TBL] [Abstract][Full Text] [Related]
12. Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies.
Vodicka E; Zimmermann M; Lopez AL; Silva MW; Gorgolon L; Kohei T; Mooney J; Muhib F; Pecenka C; Marfin AA
Vaccine; 2020 Mar; 38(13):2833-2840. PubMed ID: 32085954
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
Villanueva-Uy MET; Lam HY; Aldaba JG; Uy TMZ; Valverde HA; Silva MWT; Mooney J; Clark A; Pecenka C
Vaccine; 2021 Nov; 39(48):7091-7100. PubMed ID: 34753614
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
15. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
Anwari P; Debellut F; Pecenka C; Parwiz SM; Clark A; Groman D; Safi N
Vaccine; 2018 Dec; 36(51):7769-7774. PubMed ID: 29107346
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of rotavirus vaccination in Albania.
Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S
Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162
[TBL] [Abstract][Full Text] [Related]
17. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
[TBL] [Abstract][Full Text] [Related]
18. Health and economic impact of rotavirus vaccination in GAVI-eligible countries.
Kim SY; Sweet S; Slichter D; Goldie SJ
BMC Public Health; 2010 May; 10():253. PubMed ID: 20470426
[TBL] [Abstract][Full Text] [Related]
19. Vaccination coverage and factors associated with routine childhood vaccination uptake in rural Vellore, southern India, 2017.
Francis MR; Nuorti JP; Kompithra RZ; Larson H; Balraj V; Kang G; Mohan VR
Vaccine; 2019 May; 37(23):3078-3087. PubMed ID: 31040085
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
